HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jörg Sahlmann Selected Research

methanesulfonyl fluoride

5/2013A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jörg Sahlmann Research Topics

Disease

2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 01/2021
2Neoplasms (Cancer)
01/2021 - 10/2019
1Lung Neoplasms (Lung Cancer)
07/2021
1Hyperplasia
10/2019
1Breast Neoplasms (Breast Cancer)
07/2017
1Alzheimer Disease (Alzheimer's Disease)
05/2013

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
07/2021 - 01/2021
1ChromatinIBA
10/2019
1Perilipin-2IBA
10/2019
1Sorafenib (BAY 43-9006)FDA Link
07/2017
1Paclitaxel (Taxol)FDA LinkGeneric
07/2017
1Cholinesterase Inhibitors (Anticholinesterases)IBA
05/2013
1methanesulfonyl fluorideIBA
05/2013